{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:20:55Z","timestamp":1790389255406,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10633-025-10021-6","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:12:05Z","timestamp":1746846725000},"page":"57-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of visual function and morphological changes in patients with adrenoleukodystrophy using SS-OCT and PVEP"],"prefix":"10.1007","volume":"151","author":[{"given":"Yongqiu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangcheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-9483","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"10021_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J, Douar AM, Sarde CO et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726\u2013730. https:\/\/doi.org\/10.1038\/361726a0","journal-title":"Nature"},{"key":"10021_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.101","volume":"49","author":"L Bezman","year":"2001","unstructured":"Bezman L, Moser AB, Raymond GV et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49:512\u2013517","journal-title":"Ann Neurol"},{"key":"10021_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Schaumburg HH, Powers J et al (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26:851\u2013860. https:\/\/doi.org\/10.1111\/j.1471-4159.1976.tb04462.x","journal-title":"J Neurochem"},{"key":"10021_CR4","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ana.410070607","volume":"7","author":"HW Moser","year":"1980","unstructured":"Moser HW, Moser AB, Kawamura N et al (1980) Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol 7:542\u2013549. https:\/\/doi.org\/10.1002\/ana.410070607","journal-title":"Ann Neurol"},{"key":"10021_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0161-6420(87)33504-3","volume":"94","author":"EI Traboulsi","year":"1987","unstructured":"Traboulsi EI, Maumenee IH (1987) Ophthalmologic manifestations of X-linked childhood adrenoleukodystrophy. Ophthalmology 94:47\u201352. https:\/\/doi.org\/10.1016\/s0161-6420(87)33504-3","journal-title":"Ophthalmology"},{"key":"10021_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0002-9394(76)90498-0","volume":"82","author":"SH Wray","year":"1976","unstructured":"Wray SH, Cogan DG, Kuwabara T et al (1976) Adrenoleukodystrophy by disease of the eye and optic nerve. Am J Ophthalmol 82:480\u2013485. https:\/\/doi.org\/10.1016\/0002-9394(76)90498-0","journal-title":"Am J Ophthalmol"},{"key":"10021_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/01658107.2014.950430","volume":"38","author":"Y Ohkuma","year":"2014","unstructured":"Ohkuma Y, Hayashi T, Yoshimine S et al (2014) Retinal ganglion cell loss in X-linked adrenoleukodystrophy with an ABCD1 mutation (Gly266Arg). Neuro-Ophthalmology 38:331\u2013335. https:\/\/doi.org\/10.3109\/01658107.2014.950430","journal-title":"Neuro-Ophthalmology"},{"key":"10021_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00415-019-09627-z","volume":"267","author":"WJC van Ballegoij","year":"2020","unstructured":"van Ballegoij WJC, Kuijpers SC, Huffnagel IC et al (2020) Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy. J Neurol 267:679\u2013687. https:\/\/doi.org\/10.1007\/s00415-019-09627-z","journal-title":"J Neurol"},{"key":"10021_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1212\/WNL.0000000000201374","volume":"99","author":"M Engelen","year":"2022","unstructured":"Engelen M, van Ballegoij WJC, Mallack EJ et al (2022) International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach. Neurology 99:940\u2013951. https:\/\/doi.org\/10.1212\/WNL.0000000000201374","journal-title":"Neurology"},{"key":"10021_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/ene.13959","volume":"26","author":"LS Politi","year":"2019","unstructured":"Politi LS, Castellano A, Papinutto N et al (2019) Longitudinal quantitative magnetic resonance imaging in adrenomyeloneuropathy. Eur J Neurol 26:1341\u20131344. https:\/\/doi.org\/10.1111\/ene.13959","journal-title":"Eur J Neurol"},{"key":"10021_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1177\/0883073808331354","volume":"24","author":"W Furushima","year":"2009","unstructured":"Furushima W, Inagaki M, Gunji A et al (2009) Early signs of visual perception and evoked potentials in radiologically asymptomatic boys with X-linked adrenoleukodystrophy. J Child Neurol 24:927\u2013935. https:\/\/doi.org\/10.1177\/0883073808331354","journal-title":"J Child Neurol"},{"key":"10021_CR12","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.nicl.2021.102793","volume":"32","author":"SIW van de Stadt","year":"2021","unstructured":"van de Stadt SIW, Schrantee A et al (2021) Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy. NeuroImage Clinical 32:102793","journal-title":"NeuroImage Clinical"},{"key":"10021_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/ICU.0000000000000418","volume":"28","author":"NCY Chan","year":"2017","unstructured":"Chan NCY, Chan CKM (2017) The use of optical coherence tomography in neuro-ophthalmology. Curr Opin Ophthalmol 28:552\u2013557. https:\/\/doi.org\/10.1097\/ICU.0000000000000418","journal-title":"Curr Opin Ophthalmol"},{"key":"10021_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41433-022-02056-9","volume":"37","author":"S Vujosevic","year":"2023","unstructured":"Vujosevic S, Parra MM, Hartnett ME et al (2023) Optical coherence tomography as retinal imaging biomarker of neuroinflammation\/neurodegeneration in systemic disorders in adults and children. Eye (Lond) 37:203\u2013219. https:\/\/doi.org\/10.1038\/s41433-022-02056-9","journal-title":"Eye (Lond)"},{"key":"10021_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"N Cunniffe","year":"2021","unstructured":"Cunniffe N, Coles A (2021) Promoting remyelination in multiple sclerosis. J Neurol 268:30\u201344. https:\/\/doi.org\/10.1007\/s00415-019-09421-x","journal-title":"J Neurol"},{"key":"10021_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7:e34823. https:\/\/doi.org\/10.1371\/journal.pone.0034823","journal-title":"PLoS ONE"},{"key":"10021_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2019.01.006","volume":"201","author":"Y Wang","year":"2019","unstructured":"Wang Y, Rao R, Jacobs DS et al (2019) Prosthetic replacement of the ocular surface ecosystem treatment for ocular surface disease in pediatric patients with stevens-johnson syndrome. Am J Ophthalmol 201:1\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2019.01.006","journal-title":"Am J Ophthalmol"},{"key":"10021_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/01658108109004916","volume":"1","author":"WB Wilson","year":"1981","unstructured":"Wilson WB (1981) The visual system manifestations of adrenoleukodvstrophy. Neuro-Ophthalmology 1:175\u2013183. https:\/\/doi.org\/10.3109\/01658108109004916","journal-title":"Neuro-Ophthalmology"},{"key":"10021_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pediatrneurol.2013.04.012","volume":"49","author":"JJ Aquino","year":"2013","unstructured":"Aquino JJ, Sotirchos ES, Saidha S et al (2013) Optical coherence tomography in X-linked adrenoleukodystrophy. Pediatr Neurol 49:182\u2013184. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.04.012","journal-title":"Pediatr Neurol"},{"key":"10021_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jocn.2009.08.019","volume":"17","author":"BT Grainger","year":"2010","unstructured":"Grainger BT, Papchenko T, Danesh-Meyer HV (2010) Optic nerve atrophy in adrenoleukodystrophy detectable by optic coherence tomography. J Clin Neurosci 17:122\u2013124. https:\/\/doi.org\/10.1016\/j.jocn.2009.08.019","journal-title":"J Clin Neurosci"},{"key":"10021_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/acn3.51349","volume":"8","author":"WJC Ballegoij","year":"2021","unstructured":"Ballegoij WJC, Huffnagel IC, Stadt SIW et al (2021) Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy. Ann Clin Transl Neurol 8:1064\u20131072. https:\/\/doi.org\/10.1002\/acn3.51349","journal-title":"Ann Clin Transl Neurol"},{"key":"10021_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/WNO.0000000000000404","volume":"36","author":"P Manogaran","year":"2016","unstructured":"Manogaran P, Traboulsee AL, Lange AP (2016) Longitudinal study of retinal nerve fiber layer thickness and macular volume in patients with neuromyelitis optica spectrum disorder. J Neuroophthalmol 36:363\u2013368. https:\/\/doi.org\/10.1097\/WNO.0000000000000404","journal-title":"J Neuroophthalmol"},{"key":"10021_CR23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L et al (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24:1583. https:\/\/doi.org\/10.3390\/molecules24081583","journal-title":"Molecules"},{"key":"10021_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.864358","volume":"9","author":"J Yu","year":"2022","unstructured":"Yu J, Chen T, Guo X et al (2022) The role of oxidative stress and Inflammation in X-link adrenoleukodystrophy. Front Nutr 9:864358. https:\/\/doi.org\/10.3389\/fnut.2022.864358","journal-title":"Front Nutr"},{"key":"10021_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2015.05.041","volume":"88","author":"S Fourcade","year":"2015","unstructured":"Fourcade S, Ferrer I, Pujol A (2015) Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: a paradigm for axonal degeneration. Free Radical Biol Med 88:18\u201329. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.05.041","journal-title":"Free Radical Biol Med"},{"key":"10021_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2019.04.016","volume":"137","author":"M Doria","year":"2019","unstructured":"Doria M, Nury T, Delmas D et al (2019) Protective function of autophagy during VLCFA-induced cytotoxicity in a neurodegenerative cell model. Free Radic Biol Med 137:46\u201358. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.04.016","journal-title":"Free Radic Biol Med"},{"key":"10021_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/hmg\/ddn066","volume":"17","author":"S Hein","year":"2008","unstructured":"Hein S, Sch\u00f6nfeld P, Kahlert S et al (2008) Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 17:1750\u20131761. https:\/\/doi.org\/10.1093\/hmg\/ddn066","journal-title":"Hum Mol Genet"},{"key":"10021_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/brain\/awn269","volume":"132","author":"F Fortuna","year":"2009","unstructured":"Fortuna F, Barboni P, Liguori R et al (2009) Visual system involvement in patients with Friedreich\u2019s ataxia. Brain 132:116\u2013123. https:\/\/doi.org\/10.1093\/brain\/awn269","journal-title":"Brain"},{"key":"10021_CR29","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482\u20131488. https:\/\/doi.org\/10.1126\/science.283.5407.1482","journal-title":"Science"},{"key":"10021_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archopht.120.6.791","volume":"120","author":"EA Bristow","year":"2002","unstructured":"Bristow EA, Griffiths PG, Andrews RM et al (2002) The distribution of mitochondrial activity in relation to optic nerve structure. Arch Ophthalmol 120:791\u2013796. https:\/\/doi.org\/10.1001\/archopht.120.6.791","journal-title":"Arch Ophthalmol"},{"issue":"2-3","key":"10021_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510X(82)90153-8","volume":"56","author":"A Vercruyssen","year":"1982","unstructured":"Vercruyssen A, Martin JJ, Mercelis R (1982) Neurophysiological studies in adrenomyeloneuropathy. J Neurological Sci 56(2\u20133):327\u2013336. https:\/\/doi.org\/10.1016\/0022-510X(82)90153-8","journal-title":"J Neurological Sci"},{"key":"10021_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.clinph.2017.12.011","volume":"129","author":"S Yag\u00fce","year":"2018","unstructured":"Yag\u00fce S, Veciana M, Casasnovas C et al (2018) Evaluation of afferent pain pathways in adrenomyeloneuropathic patients. Clin Neurophysiol 129:507\u2013515. https:\/\/doi.org\/10.1016\/j.clinph.2017.12.011","journal-title":"Clin Neurophysiol"},{"key":"10021_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0022-510x(92)90028-j","volume":"110","author":"C Theda","year":"1992","unstructured":"Theda C, Moser AB, Powers JM et al (1992) Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci 110:195\u2013204. https:\/\/doi.org\/10.1016\/0022-510x(92)90028-j","journal-title":"J Neurol Sci"},{"key":"10021_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","volume":"98","author":"J Berger","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS (2014) Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 98:135\u2013142. https:\/\/doi.org\/10.1016\/j.biochi.2013.11.023","journal-title":"Biochimie"},{"key":"10021_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cell.2013.11.044","volume":"156","author":"N Snaidero","year":"2014","unstructured":"Snaidero N, M\u00f6bius W, Czopka T et al (2014) Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156:277\u2013290. https:\/\/doi.org\/10.1016\/j.cell.2013.11.044","journal-title":"Cell"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-025-10021-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:41:21Z","timestamp":1757169681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-025-10021-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10021"],"URL":"https:\/\/doi.org\/10.1007\/s10633-025-10021-6","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (the Medical Ethics Committee of Daping Hospital, Third Military Medical University) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}